Literature DB >> 7489416

Infection of human tonsil histocultures: a model for HIV pathogenesis.

S Glushakova1, B Baibakov, L B Margolis, J Zimmerberg.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7489416     DOI： 10.1038/nm1295-1320

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  79 in total

1.  Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

Authors:  S Glushakova; Y Yi; J C Grivel; A Singh; D Schols; E De Clercq; R G Collman; L Margolis
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue.

Authors:  J C Grivel; N Malkevitch; L Margolis
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.

Authors:  B Schramm; M L Penn; R F Speck; S Y Chan; E De Clercq; D Schols; R I Connor; M A Goldsmith
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.

Authors:  Françoise Gondois-Rey; Angelique Biancotto; Marcelo Antonio Fernandez; Lise Bettendroffer; Jana Blazkova; Katerina Trejbalova; Marjorie Pion; Ivan Hirsch
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system disease.

Authors:  Daniele C Cary; Janice E Clements; Andrew J Henderson
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

6.  Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.

Authors:  Ingrid Karlsson; Jean-Charles Grivel; Silvia Sihui Chen; Anders Karlsson; Jan Albert; Eva Maria Fenyö; Leonid B Margolis
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells.

Authors:  Patricia Fletcher; Yana Kiselyeva; Greg Wallace; Joseph Romano; George Griffin; Leonid Margolis; Robin Shattock
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Real-time PCR assay of individual human immunodeficiency virus type 1 variants in coinfected human lymphoid tissues.

Authors:  Yoshinori Ito; Jean-Charles Grivel; Leonid Margolis
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.

Authors:  Christophe Vanpouille; Andrea Lisco; Marco Derudas; Elisa Saba; Jean-Charles Grivel; Beda Brichacek; Francesca Scrimieri; Raymond Schinazi; Dominique Schols; Christopher McGuigan; Jan Balzarini; Leonid Margolis
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

10.  Immune suppression of human lymphoid tissues and cells in rotating suspension culture and onboard the International Space Station.

Authors:  Wendy Fitzgerald; Silvia Chen; Carl Walz; Joshua Zimmerberg; Leonid Margolis; Jean-Charles Grivel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-12       Impact factor: 2.416
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.